Scaffolding Leading to Decline in the Breast Cancer Recurrence Rate in the Patients

Release Date: 04-Nov-2020

A major limiting factor in most of the cancer therapies or treatment is the chances of cancer recurrence. But now novel findings from QUT study have found that a novel three-dimensional printed porous scaffold when combined with novel chemotherapy drugs can help in the chances of recurrence in case of breast cancer. The primary aim of the researchers in this respective study is to deliver the sustained release chemotherapy drugs using the novel 3D scaffolds. It has been found that the scaffolds that have been developed by the researchers for reducing the chances of breast cancer recurrence can also reduce the whole-body toxicity level by targeting specifically to the tumor areas.


The chemotherapy drug that was used by the researchers to combine with the developed 3D scaffold was doxorubicin. As per the researchers working on the respective study, this respective soaking method was quite simple and has the capability to work with different types of drugs such as different chemotherapeutic and antibiotics which are believed to have high therapeutic value in the cancer patients. It is also estimated that this also has the ability to retain the activity and efficacy of the drugs for long period of time.


According to the researchers working on it, the future experiments for the same will be used to study the DOX dosage optimization and accessibility for the regeneration of novel breast tissues. It is believed that the complete arrival of the therapeutics study will be responsible for completely revolutionizing the cancer therapeutics market as well as the lives of the cancer patients to much extent. It is believed that in the next few years, the clinical data from the respective study will be published, leading to a phase where cancer recurrence probability will not be any area to get concerned.

Need custom market research solution? We can help you with that too.